Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1989-6-22
|
pubmed:abstractText |
Human adenovirus types 2 and 5 (Ad2/5) cause persistent infections in man. Ad2/5 infection of rodent cells induces increased susceptibility to NK lymphocyte-mediated lysis that is dependent on target cell expression of Ad2/5 E1A gene products. In contrast to infected rodent cells, Ad2/5 infection of human fibroblasts and epithelial cells does not result in increased susceptibility to either human or rodent NK cell-mediated killing, despite high levels of E1A protein expression. This functional inactivity of E1A gene products in Ad-infected human cells may contribute to adenoviral persistence by rendering the NK cell response to Ad-infected cells ineffective.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
142
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4022-6
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2541204-Adenoviridae Infections,
pubmed-meshheading:2541204-Adenovirus Early Proteins,
pubmed-meshheading:2541204-Adenovirus Infections, Human,
pubmed-meshheading:2541204-Animals,
pubmed-meshheading:2541204-Cell Line,
pubmed-meshheading:2541204-Cricetinae,
pubmed-meshheading:2541204-Cytotoxicity, Immunologic,
pubmed-meshheading:2541204-Humans,
pubmed-meshheading:2541204-Immunity, Cellular,
pubmed-meshheading:2541204-Immunity, Innate,
pubmed-meshheading:2541204-Killer Cells, Natural,
pubmed-meshheading:2541204-Mesocricetus,
pubmed-meshheading:2541204-Molecular Weight,
pubmed-meshheading:2541204-Oncogene Proteins, Viral,
pubmed-meshheading:2541204-Species Specificity
|
pubmed:year |
1989
|
pubmed:articleTitle |
Adenovirus persistence in man. Defective E1A gene product targeting of infected cells for elimination by natural killer cells.
|
pubmed:affiliation |
Robert W. Lisle Research Laboratory, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|